FGF21 has been shown to play a key role in the control of many aspects of energy homeostasis in both preclinical and clinical studies, and it represents an interesting candidate for the treatment of obesity and type 2 diabetes (Dolegowska et al., 2019). The gene discussed is FGF21; the disease is Obesity.